GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated ...

Pulmonary arterial hypertension (PAH) is a rare, progressive, and often fatal cardiopulmonary condition characterized by pulmonary vascular remodeling and progressive narrowing, leading to increased ...

Learn the causes, symptoms, and treatment options for pulmonary hypertension—a serious condition affecting blood pressure in ...

Pulmonary arterial hypertension (PAH) is a severe disease with poor prognosis and shortened life expectancy. Treatment has traditionally involved the sequential use of endothelin receptor agonists, ...

Some small series have reported 6-month post-transplant survival of 69% for selected patients with SSc-PAH compared with 79% for iPAH, with early deaths related to primary graft dysfunction and ...

Pulmonary Circulation, Vol. 5, No. 1 (March 2015), pp. 204-210 (7 pages) AbstractPeripheral pulmonary artery stenosis (PPAS) is an underrecognized condition in the adult population. PPAS can lead to ...

Please provide your email address to receive an email when new articles are posted on . Hospitalizations for pulmonary hypertension have increased from 1980 to 2002, resulting in 200,000 ...

PULMONARY hypertension is a serious and relatively frequent complication of the ostiumsecundum type of defect of the atrial septum. 1–4 It increases the symptoms and disability of cardio-respiratory ...

Post-transplant lymphoproliferative disorder 1.6 2.1 Other 1 1.3 Adapted with permission from [20]. † Patients with poor hemodynamics at presentation can respond well to iv. epoprostenol. Patients ...

Pulmonary hypertension refers to high blood pressure in your pulmonary arteries. Your pulmonary arteries are the blood vessels that carry oxygen-poor blood from your heart to your lungs. Pulmonary ...